To be a global, people-centred, diversified healthcare organisation.
We are able to realise this vision as we support it with our four strategic pillars:
from continuing operations +4.0% to R13.0 billion
Normalised EBITDA* from continuing operations of R2.4 billion
Cash generated from
operations of R2.3 billion
Normalised earnings per share (NEPS)*
from continuing operations –2.4% to 52.8 cents
Completed disposal of Scanmed for a total cash consideration of R733 million
Strong financial position with
available undrawn facilities of R6.4 billion
Our five core values
We aim to leave a lasting impression of understanding and meeting our patients’ needs.
We achieve this by focusing on our five core values:
Passion for people
those that are the life of our business
quality to the power of e (ethics, excellence, empowerment, empathy, energy)
we act for the right reasons, with quality in mind
adding the human touch
with our patients at the very centre
Thoughtfulness goes a long way, so we aim to leave a lasting impression of understanding, of meeting patients’ needs, and really listening to them.
Life Healthcare had a positive trading performance for the period ended 31 March 2021 (H1 2021, or the current period), particularly given the continuing impact of the COVID‑19 pandemic (COVID‑19).
During the current period, the Group experienced the full impact of the second COVID‑19 wave, whereas the effect of the first COVID‑19 wave in six months ended 31 March 2020 (H1 2020, or the prior period) was felt primarily in the international business, with the southern African business impacted for only a two-week period in March 2020.